β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease

E Arif, D Medunjanin, A Solanki, X Zuo… - American Journal …, 2024 - journals.physiology.org
We have previously shown that the long-acting β2-adrenergic receptor (β2-AR) agonist
formoterol induced recovery from acute kidney injury in mice. To determine whether …
被引用次数：1 相关文章

Beta 2 adrenergic receptor agonists as a treatment for diabetic kidney disease

E Arif, D Medunjanin, A Solanki, X Zuo, Y Su, Y Dang… - journals.physiology.org
Beta 2 adrenergic receptor agonists as a treatment for diabetic kidney disease Page 1 Beta 2
adrenergic receptor agonists as a treatment for diabetic kidney disease Ehtesham Arif*1 …

Beta 2 adrenergic receptor agonists as a treatment for diabetic kidney disease.

E Arif, D Medunjanin, A Solanki, X Zuo… - American Journal of …, 2023 - europepmc.org
We previously showed that the long-acting β 2-AR agonist formoterol induced recovery from
AKI in mice. To determine if formoterol protected against diabetic nephropathy, the most …

β2-Adrenergic receptor agonists as a treatment for diabetic kidney disease

E Arif, D Medunjanin, A Solanki… - American journal …, 2024 - pubmed.ncbi.nlm.nih.gov
We have previously shown that the long-acting β 2-adrenergic receptor (β 2-AR) agonist
formoterol induced recovery from acute kidney injury in mice. To determine whether …